Literature DB >> 12442267

Identification of 14 novel CTNS mutations and characterization of seven splice site mutations associated with cystinosis.

Vasiliki Kalatzis1, Lola Cohen-Solal, Béatrice Cordier, Yaacov Frishberg, Markus Kemper, E Matti Nuutinen, Eric Legrand, Pierre Cochat, Corinne Antignac.   

Abstract

Cystinosis is an autosomal recessive disorder characterized by intra-lysosomal accumulation of cystine. Three disease forms exist, infantile, juvenile, and ocular nonnephropathic cystinosis, delineated on the basis of severity of symptoms and age of onset. Mutations in the causative gene, CTNS, which encodes cystinosin, the seven transmembrane domain lysosomal cystine transporter, have been identified in all forms confirming their allelic status. By screening for mutations in the CTNS exons and promotor region, we report 14 novel mutations associated with cystinosis: 11 underlying infantile cystinosis, two juvenile cystinosis, and one associated with an atypical form of the disease. These mutations, all situated in the exons or immediately flanking intronic sequences, comprise in-frame insertions and deletions, as well as missense, nonsense, and putative splice-site mutations. Furthermore, we confirmed the putative splice-site mutations we have reported to date (five novel and two previously reported) by isolation of RNA from the affected carriers and characterization of the resultant transcripts using RT-PCR. Since the cloning of CTNS, we have screened for mutations in 108 affected individuals, which has resulted in a high mutation detection rate of 95.8%. Interestingly, the few undetectable mono- or bi-allelic mutations segregated mostly in the noninfantile forms, suggesting that these individuals carry mutations either in the introns or in unidentified regulatory sequences. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12442267     DOI: 10.1002/humu.10141

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  16 in total

1.  Evaluation of topical cysteamine therapy in the CTNS(-/-) knockout mouse using in vivo confocal microscopy.

Authors:  Jennifer L Simpson; Chyong Jy Nien; Kevin J Flynn; James V Jester
Journal:  Mol Vis       Date:  2011-10-08       Impact factor: 2.367

2.  Clinical utility gene card for: cystinosis.

Authors:  Elena Levtchenko; Lambertus van den Heuvel; Francesco Emma; Corinne Antignac
Journal:  Eur J Hum Genet       Date:  2013-09-18       Impact factor: 4.246

3.  Rab38 modulates proteinuria in model of hypertension-associated renal disease.

Authors:  Artur Rangel-Filho; Jozef Lazar; Carol Moreno; Aron Geurts; Howard J Jacob
Journal:  J Am Soc Nephrol       Date:  2013-01-04       Impact factor: 10.121

4.  Slow progression of renal failure in a child with infantile cystinosis.

Authors:  Maria Bitsori; Eleni Vergadi; Emmanouil Galanakis
Journal:  CEN Case Rep       Date:  2018-02-14

5.  A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety.

Authors:  Craig B Langman; Larry A Greenbaum; Minnie Sarwal; Paul Grimm; Patrick Niaudet; Georges Deschênes; Elisabeth Cornelissen; Denis Morin; Pierre Cochat; Debora Matossian; Segolene Gaillard; Mary Jo Bagger; Patrice Rioux
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-03       Impact factor: 8.237

Review 6.  New aspects of the pathogenesis of cystinosis.

Authors:  Vasiliki Kalatzis; Corinne Antignac
Journal:  Pediatr Nephrol       Date:  2003-02-27       Impact factor: 3.714

7.  Intellectual and motor performance, quality of life and psychosocial adjustment in children with cystinosis.

Authors:  Francis F Ulmer; Markus A Landolt; Russia Ha Vinh; Thierry A G M Huisman; Thomas J Neuhaus; Bea Latal; Guido F Laube
Journal:  Pediatr Nephrol       Date:  2009-03-18       Impact factor: 3.714

8.  Mutational Spectrum of the CTNS Gene in Egyptian Patients with Nephropathic Cystinosis.

Authors:  Neveen A Soliman; Mohamed A Elmonem; Lambertus van den Heuvel; Rehab H Abdel Hamid; Mohamed Gamal; Inge Bongaers; Sandrine Marie; Elena Levtchenko
Journal:  JIMD Rep       Date:  2014-01-25

9.  Analysis of CTNS gene transcripts in nephropathic cystinosis.

Authors:  Anna Taranta; Martijn J Wilmer; Lambert P van den Heuvel; Paola Bencivenga; Francesco Bellomo; Elena N Levtchenko; Francesco Emma
Journal:  Pediatr Nephrol       Date:  2010-03-30       Impact factor: 3.714

10.  Late-onset nephropathic cystinosis: clinical presentation, outcome, and genotyping.

Authors:  Aude Servais; Vincent Morinière; Jean-Pierre Grünfeld; Laure-Hélène Noël; Jean-Michel Goujon; Bernadette Chadefaux-Vekemans; Corinne Antignac
Journal:  Clin J Am Soc Nephrol       Date:  2008-01       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.